Tuesday, June 25, 2013

Top Medicare Prescribers Rake In Speaking Fees From Drugmakers

Top Medicare Prescribers Rake In Speaking Fees From Drugmakers

by Charles Ornstein, Tracy Weber and Jennifer LaFleur
ProPublica, June 25, 2013, 12:02 a.m.

This story was co-published with NPR

When the blood pressure drug Bystolic hit the market in 2008, it faced a crowded field of cheap generics. 
So its maker, Forest Laboratories, launched a promotional assault on the group in the best position to determine Bystolic's success: those in control of prescription pads. It flooded the offices of health professionals with drug reps, and it hired doctors to persuade their peers to choose Bystolic — even though the drug hadn't proved more effective than competitors. 
The strategy worked. In the 2012 fiscal year, sales of Bystolic reached $348 million, almost double its total from two years earlier, the company reported. 
Now, data obtained and analyzed by ProPublica suggest another factor in Bystolic's rapid success: Many of the drug's top prescribers have financial ties to Forest. 
At least 17 of the top 20 Bystolic prescribers in Medicare's prescription drug program [2] in 2010 have been paid by Forest to deliver promotional talks. In 2012, they together received $283,450 for speeches and more than $20,000 in meals............ 
 

Full article available here.........

No comments:

Post a Comment